Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 213

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Relationship of baseline HbA1c and efficacy of current glucose‐lowering therapies: a meta‐analysis of randomized clinical trials

DeFronzo, R. A., Stonehouse, A. H., Han, J., Wintle, M. E.·2010·Diabetic Medicine

Abstract

Diabet. Med. 27, 309–317 (2010) Aims Baseline glycated haemoglobin (HbA 1c) concentrations vary between clinical trials of glucose‐lowering agents and this may affect interpretation of clinical efficacy. The objective of this study is to quantify the relationship between baseline HbA 1c and reduction of HbA 1c in clinical trials. Methods PubMed literature searches from 1991 to 2007. Randomized controlled studies with placebo‐controlled or comparator arms [≥ 9 patients in the intent‐to‐treat (ITT) population] ranging in duration from 23 to 52 weeks, in which baseline and change in glycated haemoglobin (HbA 1c) were reported. The relationship between baseline HbA 1c and change in HbA 1c was analysed by a weighted least‐squared regression model accounting for ITT population and variance of HbA 1c change. Fourteen per cent of independently abstracted studies met the selection criteria. Results Meta‐analysis from 59 clinical trials (8479 patients) produced weighted R2 of 0.35 (P < 0.0001) for the association of baseline HbA 1c and absolute change in HbA 1c. Subanalysis of eight metformin clinical trials demonstrated a stronger association [weighted R2 of 0.67 (P = 0.0130)]. Exclusion of metformin clinical trials from the overall meta‐analysis (n = 51) yielded a weighted R2 of 0.31 (P < 0.0001). Subanalyses of clinical trials of glucose‐lowering therapies predominantly targeting fasting (n = 37) or postprandial (n = 22) blood glucose produced weighted R2 values of 0.27 (P < 0.001) and 0.42 (P < 0.005), respectively. Conclusions These data demonstrate a positive relationship between baseline HbA 1c and the magnitude of HbA 1c change across 10 categories of glucose‐lowering therapies, irrespective of class or mode of action. These observations should be considered when assessing clinical efficacy of diabetes therapies derived from clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.02941.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 213

Metadata

Authors
DeFronzo, R. A., Stonehouse, A. H., Han, J., & Wintle, M. E.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-03
Volume
27
Issue
3
Pages
309-317
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2071770035
Cited by
213
References
13
FWCI
11.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationship of baseline HbA1c and efficacy of current glucose‐lowering therapies: a meta‐analysis of randomized clinical trials. https://app.cochat.ai/papers/10.1111/j.1464-5491.2010.02941.x
The paper
DeFronzo, R. A., Stonehouse, A. H., Han, J., & Wintle, M. E. (2010). Relationship of baseline HbA1c and efficacy of current glucose‐lowering therapies: a meta‐analysis of randomized clinical trials. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2010.02941.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.